Kingsman Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,537
Closed -$222K 78
2026
Q1
$222K Sell
3,537
-7,343
-67% -$587K 0.12% 64
2025
Q4
$1.04M Sell
10,880
-13,411
-55% -$1.31M 0.56% 26
2025
Q3
$2.37M Sell
24,291
-9,142
-27% -$947K 1.32% 15
2025
Q2
$3.59M Buy
33,433
+6,622
+25% +$670K 2.24% 12
2025
Q1
$2.7M Buy
+26,811
New +$2.7M 1.98% 14

Other funds holding BSX

Kingsman Wealth Management's BSX Position: Q2 2026 in Review

Kingsman Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,537 shares — an estimated $222K sold.

Kingsman Wealth Management first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $3.59M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kingsman Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Kingsman Wealth Management sold 3,537 Boston Scientific shares in Q2 2026, an estimated $222K.
  • Kingsman Wealth Management first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
  • Kingsman Wealth Management's Boston Scientific position peaked at $3.59M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kingsman Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.